Developer docs
API playgroundTry for free, no card

Search company profiles

Companion Spine

Full company profile

uuid0004ysk

Namestring
Companion Spine
Legal namestring
Companion Spine France SAS
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Companion Spine is a privately held French-American medical technology company specializing in motion-preserving spinal implants for the interventional treatment of degenerative disc disease (DDD), lumbar spinal stenosis, and related chronic back conditions. Founded in 2019, the company is headquartered in Mérignac, France with US operations based in New York, NY, and Leesburg, VA. Its stated mission is to provide reversible, minimally invasive alternatives to traditional spinal fusion surgery, spanning the full continuum of spine care from diagnostics through surgical intervention. The company employs 11-50 people and has raised approximately $60-65 million in Series A funding.

The company's product portfolio comprises four core devices built around posterior dynamic stabilization technology: the DIAM™ Spinal Stabilization System (FDA Premarket Approved in December 2025 for DDD, with over 200,000 implants performed across 76 countries), the LISA™ Posterior Dynamic Stabilization System (CE-certified under EU MDR, a third-generation device based on 35 years of clinical research, not currently available in the US), the coflex® Interlaminar Stabilization Device (FDA PMA-approved for one- or two-level lumbar stenosis at L1-L5), and the CoFix™ Implant (FDA 510(k)-cleared titanium posterior fixation adjunct for lumbar fusion support). Three of the four products were added through acquisitions—BACKBONE SAS in January 2023 (LISA) and Paradigm Spine GmbH from Xtant Medical Holdings in December 2025 for approximately $21.4 million (coflex and CoFix)—reflecting a programmatic M&A-driven portfolio assembly strategy.

Companion Spine generates revenue through direct hardware sales of spinal implants to hospitals, ambulatory surgery centers (ASCs), spine surgeons, and pain management physicians, supplemented by an international distributor network across Europe and Asia. Its go-to-market combines enterprise field sales with physician seminars, clinical training programs, surgeon case observations, and presence at major spine conferences including Eurospine and ISASS. Pricing is not publicly disclosed and follows typical med-device quote-based contracting that varies by procedure, facility, and contract terms.

Short descriptiontext

Companion Spine is a French-American medical device company developing motion-preserving spinal implants—including DIAM, LISA, coflex, and CoFix—for the interventional treatment of degenerative disc disease and lumbar spinal stenosis, selling to spine surgeons, pain physicians, and ambulatory surgery centers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spinal implants, motion-preserving devices, minimally invasive spine surgery, dynamic spinal stabilization, degenerative disc treatment
Industry1 code
1Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
CodeHLAHAEACPrimaryYes
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Spinal Implants
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Spinal Implant Sales
TypeHardware Sales
Description

Companion Spine generates revenue through the sale of its proprietary spinal implants and stabilization systems to healthcare providers, hospitals, and ambulatory surgery centers.

companion-spine.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1DIAM
Description

DIAM Spinal Stabilization System - a motion-preserving posterior device for treating degenerative disc disease, FDA-approved in December 2025

companion-spine.com
+3 more records
Core offering1 text field

Companion Spine develops, manufactures, and sells proprietary motion-preserving spinal implants and minimally invasive surgical technologies for treating degenerative disc disease, lumbar spinal stenosis, and injury-related back pain. Its product portfolio includes DIAM, LISA, coflex, and CoFix systems, sold to spine surgeons, pain management physicians, hospitals, and ambulatory surgery centers worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 200,000 DIAM implants performed globally across 76 countries
+1 more record
Product overview1 text field

Companion Spine is a medical device company offering a portfolio of motion-preserving and minimally invasive spinal implants for treating degenerative disc disease and lumbar spinal stenosis. The company's product portfolio includes four core devices: DIAM™ (FDA PMA-approved for DDD), coflex® (FDA PMA-approved for lumbar stenosis), CoFix™ (FDA 510k-approved for fusion support), and LISA™ (CE-certified dynamic stabilization). The company focuses on providing interventional therapies and technologies for back pain resolution with minimal disruption to quality of life, targeting conditions including degenerative disc disease, spinal stenosis, and injury-related pain.

Product and service4 records
1DIAM Spinal Stabilization System
CategorySpinal Implants
Description

FDA PMA-approved dynamic spinal stabilization device for treating degenerative disc disease and low back pain. Placed between vertebrae to share load borne by the disc and maintain vertebral height while preserving spinal motion. Targeted at spine surgeons and pain management physicians treating degenerative disc disease in hospitals and ambulatory surgery centers.

2coflex Interlaminar Stabilization System
CategorySpinal Implants
Description

FDA PMA-approved titanium interlaminar stabilization device for lumbar spinal stenosis. Combines stability with natural motion preservation; implanted midline between adjacent lamina of 1 or 2 contiguous lumbar motion segments (L1-L5) after decompression in skeletally mature patients. For spine surgeons treating moderate to severe lumbar stenosis.

3CoFix Implant
CategorySpinal Implants
Description

FDA 510(k)-cleared titanium posterior non-pedicle supplemental fixation device for lumbar fusion support. Wing and screw design provides secure fixation to adjacent spinous processes as an adjunct to interbody cage fusion at a single level (L1-S1). For spine surgeons performing lumbar fusion in patients with degenerative disc disease.

4LISA Posterior Dynamic Stabilization System
CategorySpinal Implants
Description

CE-certified under EU MDR dynamic stabilization device for treating degenerative disc disease and low back pain at L1-L5 levels. A third-generation device invented in 1986 based on 35 years of clinical research, providing stiffness augmentation while preserving motion and anatomy in a fully reversible, minimally invasive procedure. For spine surgeons and pain management physicians in Europe and Asia (not yet available in the US).

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

Companion Spine completed acquisition of Paradigm Spine GmbH and all related assets from Xtant Medical Holdings in December 2025. This acquisition expanded Companion Spine's product portfolio to include coflex and CoFix spinal stabilization implants, establishing the company as a global leader in posterior dynamic spine stabilization.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Spine device company specializing in motion-preserving total disc replacement (prodisc) — the most direct non-fusion peer to Companion Spine's posterior dynamic stabilization portfolio, and previously founded by CEO Anthony Viscogliosi.

TypeDirect peer
Description

Public spine and orthopedics company offering motion-preservation and fusion implants with a US sales force focused on surgeons and ASCs — directly comparable customer base and product overlap with Companion Spine.

TypeDirect peer
Description

Spine-only public company focused on lateral and minimally invasive fusion and motion-preservation technologies, with a US surgeon sales force comparable in scale to Companion Spine's growth-stage commercial operations.

TypeBroad incumbent
Description

Spun off spine business of Zimmer Biomet offering motion-preservation and fusion products including the Mobi-C cervical disc — broad incumbent with overlapping posterior stabilization and cervical motion-preservation products.

TypeBroad incumbent
Description

Large incumbent spine franchise (post-K2M acquisition) offering cervical and lumbar motion-preservation devices including the MESA and Tritanium systems — broad portfolio with overlapping degenerative disc and stenosis indications.

TypeBroad incumbent
Description

Largest spine medtech incumbent offering Prestige LP and Bryan cervical discs plus comprehensive lumbar portfolio — the dominant competitive benchmark for any spine motion-preservation entrant.

TypeBroad incumbent
Description

Major spine incumbent formed via NuVasive merger, with broad motion-preservation and enabling-technology portfolio — competitor across Companion Spine's lumbar stenosis and degenerative disc indications.

TypeEmerging player
Description

Spine-focused company that divested coflex, CoFix, and Paradigm Spine assets to Companion Spine for ~$21.4M — comparable in scale and adjacent in product portfolio, representing the most recent seller-side peer.

TypeEmerging player
Description

Emerging spine company developing the TOPS posterior motion-preservation system — closely analogous motion-preserving lumbar technology targeting the same degenerative disc disease and stenosis indications as DIAM and coflex.

TypeEmerging player
Description

Privately held spine company offering motion-preservation and fusion implants across Europe and the US — comparable French/Swiss-origin mid-market spine competitor to Companion Spine's European franchise.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Companion Spine

Spinal Implantscompanion-spine.com

Companion Spine is a French-American medical device company developing motion-preserving spinal implants—including DIAM, LISA, coflex, and CoFix—for the interventional treatment of degenerative disc disease and lumbar spinal stenosis, selling to spine surgeons, pain physicians, and ambulatory surgery centers globally.

What Companion Spine does

Companion Spine is a privately held French-American medical technology company specializing in motion-preserving spinal implants for the interventional treatment of degenerative disc disease (DDD), lumbar spinal stenosis, and related chronic back conditions. Founded in 2019, the company is headquartered in Mérignac, France with US operations based in New York, NY, and Leesburg, VA. Its stated mission is to provide reversible, minimally invasive alternatives to traditional spinal fusion surgery, spanning the full continuum of spine care from diagnostics through surgical intervention. The company employs 11-50 people and has raised approximately $60-65 million in Series A funding.

The company's product portfolio comprises four core devices built around posterior dynamic stabilization technology: the DIAM™ Spinal Stabilization System (FDA Premarket Approved in December 2025 for DDD, with over 200,000 implants performed across 76 countries), the LISA™ Posterior Dynamic Stabilization System (CE-certified under EU MDR, a third-generation device based on 35 years of clinical research, not currently available in the US), the coflex® Interlaminar Stabilization Device (FDA PMA-approved for one- or two-level lumbar stenosis at L1-L5), and the CoFix™ Implant (FDA 510(k)-cleared titanium posterior fixation adjunct for lumbar fusion support). Three of the four products were added through acquisitions—BACKBONE SAS in January 2023 (LISA) and Paradigm Spine GmbH from Xtant Medical Holdings in December 2025 for approximately $21.4 million (coflex and CoFix)—reflecting a programmatic M&A-driven portfolio assembly strategy.

Companion Spine generates revenue through direct hardware sales of spinal implants to hospitals, ambulatory surgery centers (ASCs), spine surgeons, and pain management physicians, supplemented by an international distributor network across Europe and Asia. Its go-to-market combines enterprise field sales with physician seminars, clinical training programs, surgeon case observations, and presence at major spine conferences including Eurospine and ISASS. Pricing is not publicly disclosed and follows typical med-device quote-based contracting that varies by procedure, facility, and contract terms.

Companion Spine firmographics

Firmographics
Name
Companion Spine
Legal name
Companion Spine France SAS
Website
https://companion-spine.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Companion Spine is a French-American medical device company developing motion-preserving spinal implants—including DIAM, LISA, coflex, and CoFix—for the interventional treatment of degenerative disc disease and lumbar spinal stenosis, selling to spine surgeons, pain physicians, and ambulatory surgery centers globally.
Ownership category
akta.pro rank

Companion Spine industry classification

Industry
Product category
Spinal Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

Keywords

  • Spinal implants
  • Motion-preserving devices
  • Minimally invasive spine surgery
  • Dynamic spinal stabilization
  • Degenerative disc treatment

Where Companion Spine is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Companion Spine business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Spinal Implant Sales: Companion Spine generates revenue through the sale of its proprietary spinal implants and stabilization systems to healthcare providers, hospitals, and ambulatory surgery centers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Companion Spine product offering

Product offering

Core offering

Companion Spine develops, manufactures, and sells proprietary motion-preserving spinal implants and minimally invasive surgical technologies for treating degenerative disc disease, lumbar spinal stenosis, and injury-related back pain. Its product portfolio includes DIAM, LISA, coflex, and CoFix systems, sold to spine surgeons, pain management physicians, hospitals, and ambulatory surgery centers worldwide.

Product overview

Companion Spine is a medical device company offering a portfolio of motion-preserving and minimally invasive spinal implants for treating degenerative disc disease and lumbar spinal stenosis. The company's product portfolio includes four core devices: DIAM™ (FDA PMA-approved for DDD), coflex® (FDA PMA-approved for lumbar stenosis), CoFix™ (FDA 510k-approved for fusion support), and LISA™ (CE-certified dynamic stabilization). The company focuses on providing interventional therapies and technologies for back pain resolution with minimal disruption to quality of life, targeting conditions including degenerative disc disease, spinal stenosis, and injury-related pain.

Differentiator

Problem solved

Functional benefit

Brands

  • DIAM: DIAM Spinal Stabilization System - a motion-preserving posterior device for treating degenerative disc disease, FDA-approved in December 2025
  • LISA
  • coflex
  • CoFix

Products and services

  • DIAM Spinal Stabilization System FDA PMA-approved dynamic spinal stabilization device for treating degenerative disc disease and low back pain. Placed between vertebrae to share load borne by the disc and maintain vertebral height while preserving spinal motion. Targeted at spine surgeons and pain management physicians treating degenerative disc disease in hospitals and ambulatory surgery centers.
  • coflex Interlaminar Stabilization System FDA PMA-approved titanium interlaminar stabilization device for lumbar spinal stenosis. Combines stability with natural motion preservation; implanted midline between adjacent lamina of 1 or 2 contiguous lumbar motion segments (L1-L5) after decompression in skeletally mature patients. For spine surgeons treating moderate to severe lumbar stenosis.
  • CoFix Implant FDA 510(k)-cleared titanium posterior non-pedicle supplemental fixation device for lumbar fusion support. Wing and screw design provides secure fixation to adjacent spinous processes as an adjunct to interbody cage fusion at a single level (L1-S1). For spine surgeons performing lumbar fusion in patients with degenerative disc disease.
  • LISA Posterior Dynamic Stabilization System CE-certified under EU MDR dynamic stabilization device for treating degenerative disc disease and low back pain at L1-L5 levels. A third-generation device invented in 1986 based on 35 years of clinical research, providing stiffness augmentation while preserving motion and anatomy in a fully reversible, minimally invasive procedure. For spine surgeons and pain management physicians in Europe and Asia (not yet available in the US).

Quantifiable outcome

  • Over 200,000 DIAM implants performed globally across 76 countries
  • +1 more outcomes

Companies that use Companion Spine

Customer profile

Segments3 records

Ideal customer profiles2 records

Companion Spine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Companion Spine partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Xtant Medical HoldingscoreStrategic or Co-development Partner · 1 December 2025Companion Spine completed acquisition of Paradigm Spine GmbH and all related assets from Xtant Medical Holdings in December 2025. This acquisition expanded Companion Spine's product portfolio to include coflex and CoFix spinal stabilization implants, establishing the company as a global leader in posterior dynamic spine stabilization.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Companion Spine competitors and assessment

Company assessment

Direct peers

  • Centinel Spine: Spine device company specializing in motion-preserving total disc replacement (prodisc) — the most direct non-fusion peer to Companion Spine's posterior dynamic stabilization portfolio, and previously founded by CEO Anthony Viscogliosi.
  • Orthofix Medical: Public spine and orthopedics company offering motion-preservation and fusion implants with a US sales force focused on surgeons and ASCs — directly comparable customer base and product overlap with Companion Spine.
  • Alphatec Holdings: Spine-only public company focused on lateral and minimally invasive fusion and motion-preservation technologies, with a US surgeon sales force comparable in scale to Companion Spine's growth-stage commercial operations.

Broad incumbents

  • ZimVie (Zimmer Biomet Spine): Spun off spine business of Zimmer Biomet offering motion-preservation and fusion products including the Mobi-C cervical disc — broad incumbent with overlapping posterior stabilization and cervical motion-preservation products.
  • Stryker Spine: Large incumbent spine franchise (post-K2M acquisition) offering cervical and lumbar motion-preservation devices including the MESA and Tritanium systems — broad portfolio with overlapping degenerative disc and stenosis indications.
  • Medtronic Spine: Largest spine medtech incumbent offering Prestige LP and Bryan cervical discs plus comprehensive lumbar portfolio — the dominant competitive benchmark for any spine motion-preservation entrant.
  • Globus Medical: Major spine incumbent formed via NuVasive merger, with broad motion-preservation and enabling-technology portfolio — competitor across Companion Spine's lumbar stenosis and degenerative disc indications.

Emerging players

  • Xtant Medical Holdings: Spine-focused company that divested coflex, CoFix, and Paradigm Spine assets to Companion Spine for ~$21.4M — comparable in scale and adjacent in product portfolio, representing the most recent seller-side peer.
  • Premia Spine: Emerging spine company developing the TOPS posterior motion-preservation system — closely analogous motion-preserving lumbar technology targeting the same degenerative disc disease and stenosis indications as DIAM and coflex.
  • Spineart: Privately held spine company offering motion-preservation and fusion implants across Europe and the US — comparable French/Swiss-origin mid-market spine competitor to Companion Spine's European franchise.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

Companion Spine social profiles

Digital presence

Companion Spine compliance and trust

Trust signal

Compliance4 records

Companion Spine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Companion Spine leadership team

Management profile

Number of profiles

Profiles11 records

Companion Spine subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Companion Spine funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Companion Spine M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Companion Spine

What does Companion Spine do?

Companion Spine develops, manufactures, and sells proprietary motion-preserving spinal implants and minimally invasive surgical technologies for treating degenerative disc disease, lumbar spinal stenosis, and injury-related back pain. Its product portfolio includes DIAM, LISA, coflex, and CoFix systems, sold to spine surgeons, pain management physicians, hospitals, and ambulatory surgery centers worldwide.

Is Companion Spine a public or private company?

Companion Spine is a private company. It is classified as venture growth investor backed and is currently operating.

When was Companion Spine founded?

Companion Spine was founded in 2019. It employs 11 to 50 people.

Where is Companion Spine based?

Companion Spine is headquartered in New York, United States, in the North America region.

How does Companion Spine make money?

One revenue line is on record: spinal Implant Sales.

Who are Companion Spine's main competitors?

Direct peers on record are Centinel Spine, Orthofix Medical and Alphatec Holdings. Broad incumbents are ZimVie (Zimmer Biomet Spine), Stryker Spine, Medtronic Spine and Globus Medical. Emerging players are Xtant Medical Holdings, Premia Spine and Spineart.

Does Companion Spine have an API?

No public API is recorded for Companion Spine.

What industry is Companion Spine in?

Companion Spine's product category is Spinal Implants. Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Motley FoolXtant Medical (XTNT) Q2 2026 Earnings Call TranscriptXtant Medical Holdings, Inc. reported second quarter 2026 financial results with total revenue of $23 million, down from $35.4 million in the prior year period, driven by the sale of noncore assets to Companion Spine and the cessation of Q-Code license revenue at the end of 2025. The company posted a net loss of $9.4 million and an adjusted EBITDA loss of $2.7 million, compared to positive adjusted EBITDA of $6.9 million in Q2 2025, as integration of the Dilon Technologies sales force and transition of HEMOBLAST Bellows to company-specific contracts created short-term headwinds. Management reduced full-year 2026 revenue guidance to $99 million to $103 million from the previous range of $101 million to $105 million, citing softness in legacy biologics and amniotic product lines, while expressing optimism about the expanded commercial organization of over 25 sales reps and three national accounts managers.Investing.comXtant Medical receives $10.7 million payment from Companion Spine, prepays loan By Investing.comXtant Medical received a $10.7 million payment from Companion Spine, LLC in February 2026, which finalized the sale of certain assets and subsidiaries related to its Coflex and CoFix products. The payment included repayment of an $8.2 million promissory note, interest, and purchase price adjustments, and strengthened its financial position.Stock TitanXtant Medical sale to Companion Spine totals $21.4MXtant Medical Holdings finalized a transaction with Companion Spine, receiving $10.7 million related to the purchase of its Coflex assets and Paradigm OUS businesses. The total purchase price for these divestitures was $21.4 million, and the transaction will help Xtant reduce its long-term debt and improve liquidity.PR NewswireXtant Medical Finalizes Companion Spine TransactionsXtant Medical Holdings has received $10.7 million from Companion Spine, completing the transactions for Companion Spine's purchase of Xtant's Coflex® assets and Paradigm OUS businesses that were divested in December 2025. The payment brings the total aggregate purchase price for both divestitures to $21.4 million, with $8.2 million representing satisfaction of the unsecured promissory note plus accrued interest, and $2.2 million related to working capital adjustments. Xtant's CEO stated the finalized transactions allow the company to sharpen its focus on higher-margin biologics business while reducing long-term debt and increasing cash liquidity.MorningstarXtant Medical Finalizes Companion Spine TransactionsXtant Medical received $10.7 million from Companion Spine related to the December 2025 sale of its Coflex® assets and Paradigm OUS businesses, bringing the total purchase price to $21.4 million. Of the recent payment, $8.2 million satisfied an unsecured promissory note plus accrued interest, with an additional $2.2 million covering working capital adjustments. The company stated these additional funds will allow it to further reduce long-term debt while providing additional cash liquidity.Business Wire BlogCompanion Spine Announces FDA Premarket Approval (“PMA”) of the DIAM™ Spinal Stabilization System for the Treatment of Degenerative Disc Disease (“DDD”)Companion Spine announced that the U.S. Food and Drug Administration (FDA) has approved its DIAM™ Spinal Stabilization System for treating degenerative disc disease (DDD), marking it as the first posterior motion-preserving device approved in the U.S. for this condition. The device, which has shown superior clinical outcomes and safety in trials, aims to address an unmet need for patients who have not benefitted from non-operative care. This milestone is seen as a significant advancement in spinal care, allowing for a less invasive treatment option.BioSpaceCompanion Spine Announces FDA Premarket Approval (“PMA”) of the DIAM™ Spinal Stabilization System for the Treatment of Degenerative Disc Disease (“DDD”)Companion Spine announced FDA Premarket Approval for its DIAM Spinal Stabilization System, making it the first posterior motion-preserving device approved in the U.S. for treating moderate to severe primary low back pain from degenerative disc disease at a single lumbar level. The approval was based on clinical trial data showing 67.4% composite clinical success at 24 months versus 11.9% for non-operative care, with durable results through an average of 11.5 years of follow-up. The FDA granted the approval without requiring a post-approval confirmatory trial, and the device had previously received Breakthrough Device Designation in October 2021.Business Wire BlogCompanion Spine LLC Completes Acquisition of the Business and Assets of Paradigm Spine GmbH, including the Coflex® and CoFix® Spine Implants and All Other Implant Systems, from Xtant™ Medical HoldingsCompanion Spine LLC has completed its previously announced acquisition of Paradigm Spine GmbH, including the Coflex® and CoFix® spine implants and all other Paradigm Spine-related business assets, from Xtant Medical Holdings, Inc. The acquisition creates the world's largest and most comprehensive product portfolio of minimally invasive surgical Posterior Dynamic Solutions for spine stabilization and motion-preserving implants. The combined company will be led by Anthony G. Viscogliosi as Executive Chairman and CEO, with Paradigm Spine retaining its name and office in Wurmlingen, Germany.MarketScreenerXtant Medical Reports Third Quarter 2025 Financial ResultsXtant Medical Holdings reported Q3 2025 financial results with revenue of $33.3 million, up 19% year-over-year, driven primarily by licensing revenue, while achieving positive net income of $1.3 million compared to a $5.0 million loss in the prior year quarter. The company also delivered adjusted EBITDA of $4.5 million versus a loss of $1.0 million in Q3 2024, with gross margin improving to 66.1% from 58.4%. Xtant reiterated its full-year 2025 revenue guidance of $131-$135 million and announced that the pending sale of its non-core Coflex and CoFix assets and all international businesses to Companion Spine is expected to close by year-end, sharpening focus on its core biologics business.TracxnTop startups in Orthopedics in New York City, United States (Oct, 2025)The article presents a list of top orthopedics startups located in New York City, United States, highlighting Formation Bio, Companion Spine, and Voom Medical Devices along with their funding stages and key product offerings. It notes that these companies have attracted significant venture capital investment, such as Formation Bio's $372 million Series D round, and are often founded by alumni from prominent business schools. The report serves as an industry overview rather than covering a specific singular corporate event or transaction.